Phase 3 HIV Infections trials recruiting now

All HIV Infections trials, every phase

Other phases for HIV Infections

Phase 3 HIV Infections trials

• A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment
  NCT07393659 · Phase: Phase 3 · Ages: No age limits stated · Sex: All (male and female) · 4 locations
• A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
  NCT07650916 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · 88 locations
• Long-Acting HIV Pre-Exposure Prophylaxis Integrated With Sexual and Reproductive Health - cRCT
  NCT06250504 · Phase: Phase 3 · Ages: 15 Years to 30 Years · Sex: All (male and female) · 1 location
• Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
  NCT07682961 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 19 locations
• The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir
  NCT05515770 · Phase: Phase 3 · Ages: 18 Years to 30 Years · Sex: Male · 1 location

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.